Idiopathic Pulmonary Fibrosis (IPF) is a progressive and largely untreatable group of disorders that affects up to 100,000 people in the United States Current proven therapies are only effective in a minority of affected individuals Despite the significant progress in understanding the general mechanisms that lead to pulmonary fibrosis in murine lungs, little is known about the molecular mechanisms and networks that determine the fibrotic pulmonary phenotype in IPF The research proposed is based on the hypothesis that the unique phenotypic aspects of IPF, temporal heterogeneity, lack of significant inflammation and abundance of myofibroblast foci, represent molecular mechanisms that are specific to IPF. Therefore, understanding the molecular networks that underlie these characteristics will lead to identification of novel rational molecular targets for intervention in IPF. This hypothesis will be tested by addressing the following specific aims: 1. To create a comprehensive expression profile of human pulmonary fibrosis. This will be achieved by identifying gene expression patterns that distinguish IPF from normal lung tissue and from other interstitial lung diseases, by identifying regional and temporal changes in gene expression and by identifying cell specific gene expression patterns in IPF lungs. 2. To identify """"""""target"""""""" pathways and regulatory molecules that are candidates for therapeutic interventions using advanced computational methods This computational aimi includes: Determination of clinically relevant patterns of expression, identification of transcriptional regulation of observed expression patterns and generation of advanced computational methods that characterize gene expression """"""""modules"""""""" and reconstruct """"""""missing"""""""" key events in disease progression from gene expression data. 3. To verify protein expression levels of candidate molecules. This will be achieved by generating tissue arrays in which all interstitial lung diseases are represented. These arrays will be used for validation, frequency determination and cellular localization of abnormalities in protein expression of candidate molecules. 4. To identify the candidate molecules that affect """"""""fibrosis related"""""""" cellular phenotypes using high throughout cell based assays. This will be done by assessing the effect of in-vitro inhibiting or inducing the expression of validated candidate molecules on ECM production and cytokine and growth factor secretion.
| Agassandian, Marianna; Tedrow, John R; Sembrat, John et al. (2015) VCAM-1 is a TGF-?1 inducible gene upregulated in idiopathic pulmonary fibrosis. Cell Signal 27:2467-73 |
| Vuga, Louis J; Milosevic, Jadranka; Pandit, Kusum et al. (2013) Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis. PLoS One 8:e83120 |
| Yu, Guoying; Kovkarova-Naumovski, Elisabetha; Jara, Paul et al. (2012) Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humans. Am J Respir Crit Care Med 186:752-62 |
| Pandit, Kusum V; Corcoran, David; Yousef, Hanadie et al. (2010) Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182:220-9 |
| Ask, Kjetil; Eickelberg, Oliver; Gauldie, Jack et al. (2010) Have advanced research technologies made real impact on respiratory medicine? Respirology 15:876-80 |
| Yousem, Samuel A; Gibson, Kevin; Kaminski, Naftali et al. (2010) The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome. Mod Pathol 23:874-80 |
| Konishi, Kazuhisa; Gibson, Kevin F; Lindell, Kathleen O et al. (2009) Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 180:167-75 |
| Vuga, Louis J; Ben-Yehudah, Ahmi; Kovkarova-Naumovski, Elizabetha et al. (2009) WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Am J Respir Cell Mol Biol 41:583-9 |
| Di Giuseppe, Michelangelo; Gambelli, Federica; Hoyle, Gary W et al. (2009) Systemic inhibition of NF-kappaB activation protects from silicosis. PLoS One 4:e5689 |
| Richards, Thomas J; Eggebeen, Aaron; Gibson, Kevin et al. (2009) Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum 60:2183-92 |
Showing the most recent 10 out of 23 publications
